This paper focuses on the potential of eosinophil-associated cytokines and growth factors as biomarkers in IBD, in reference to high-sensitive C-reactive protein, an inflammatory marker commonly used in IBD clinics [8]. Here, CRP is linked to irritable bowel syndrome.